Long-term Safety and Tolerability of Ozanimod by Age Category in Patients With Relapsing Multiple Sclerosis From Two Phase 3 Trials and an Open-Label Extension Study K. W. Selmaj,J. A. Cohen, L. Steinman, G. Comi, A. Bar-Or, H. Hartung,X. Montalban,L. Kappos, J. K. Sheffield, A. Krakovich,C. Cheng, J. Riolo,D. Silva,B. A. CreeMULTIPLE SCLEROSIS JOURNAL（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
